Haoxi Health Technology Files 2024 Annual Report

TL;DR

Haoxi Health Tech filed its 2024 20-F, check it for annual performance details.

AI Summary

Haoxi Health Technology Ltd. filed its annual report on Form 20-F for the fiscal year ended June 30, 2024. The company, incorporated in E9 and headquartered in Beijing, China, operates in the advertising agencies sector. This filing serves as an annual report, not a registration statement or transition report.

Why It Matters

This 20-F filing provides investors with a comprehensive overview of Haoxi Health Technology's financial performance and business operations for the past fiscal year, crucial for investment decisions.

Risk Assessment

Risk Level: medium — As an annual report for a company listed on a US exchange but incorporated elsewhere, it contains standard disclosures but may lack the immediate, granular detail of quarterly reports or specific event filings.

Key Numbers

• 20240630 — Fiscal Year End (The period covered by the annual report)
• 20241029 — Filing Date (The date the 20-F was submitted to the SEC)

Key Players & Entities

• Haoxi Health Technology Ltd (company) — Filer of the 20-F
• 0001954594 (company) — Central Index Key for Haoxi Health Technology Ltd
• 7311 (company) — Standard Industrial Classification code for Services-Advertising Agencies
• 001-41933 (company) — SEC File Number for Haoxi Health Technology Ltd
• 241402847 (company) — Film Number for Haoxi Health Technology Ltd
• 86-10-13311587976 (company) — Business phone number for Haoxi Health Technology Ltd

FAQ

Key Financial Figures

• $0.0001 — d Class A Ordinary Shares, par value US$0.0001 per share HAO The Nasdaq Stock Market
• $ — Exchange Commission; "U.S. dollars," "$," and "dollars" are to the legal curren
• $4.00 — 0 Class A Ordinary Shares at a price of $4.00 per share. On March 8, 2024, the underw
• $11,040,000 — ercise of the over-allotment option, is $11,040,000. On September 20, 2024 (the "Follow-on
• $3.00 — ants"), at the public offering price of $3.00 per Unit. The Class A Ordinary Shares u
• $3 — arrant Shares." Each Unit was priced at $3.00, and the Company generated gross pro
• $12,000,000, b — the Company generated gross proceeds of $12,000,000, before deducting offering expenses. This
• $1.00 — the end of the year - RMB RMB7.1268 to $1.00 RMB7.2258 to $1.00 RMB6.7114 to $1.00

Filing Documents

• ea0218492-20f_haoxi.htm (20-F) — 1559KB
• ea021849201ex2-5_haoxi.htm (EX-2.5) — 106KB
• ea021849201ex11-2_haoxi.htm (EX-11.2) — 166KB
• ea021849201ex12-1_haoxi.htm (EX-12.1) — 8KB
• ea021849201ex12-2_haoxi.htm (EX-12.2) — 8KB
• ea021849201ex13-1_haoxi.htm (EX-13.1) — 4KB
• ea021849201ex13-2_haoxi.htm (EX-13.2) — 4KB
• ea021849201ex15-1_haoxi.htm (EX-15.1) — 4KB
• ea021849201ex15-2_haoxi.htm (EX-15.2) — 2KB
• ea021849201ex97-1_haoxi.htm (EX-97.1) — 35KB
• image_001.jpg (GRAPHIC) — 47KB
• image_002.jpg (GRAPHIC) — 24KB
• image_003.jpg (GRAPHIC) — 37KB
• image_004.jpg (GRAPHIC) — 37KB
• image_005.jpg (GRAPHIC) — 153KB
• image_006.jpg (GRAPHIC) — 1KB
• image_007.jpg (GRAPHIC) — 1KB
• image_008.jpg (GRAPHIC) — 1KB
• image_009.jpg (GRAPHIC) — 40KB
• image_010.jpg (GRAPHIC) — 5KB
• image_011.jpg (GRAPHIC) — 71KB
• ex15-2_001.jpg (GRAPHIC) — 20KB
• ex15-2_002.jpg (GRAPHIC) — 23KB
• ex15-1_001.jpg (GRAPHIC) — 6KB
• 0001213900-24-091443.txt ( ) — 7508KB
• hao-20240630.xsd (EX-101.SCH) — 54KB
• hao-20240630_cal.xml (EX-101.CAL) — 44KB
• hao-20240630_def.xml (EX-101.DEF) — 248KB
• hao-20240630_lab.xml (EX-101.LAB) — 410KB
• hao-20240630_pre.xml (EX-101.PRE) — 244KB
• ea0218492-20f_haoxi_htm.xml (XML) — 514KB

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 109 ITEM 12.

DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 110 PART II 111 ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES 111 ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS 111 ITEM 15.

CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES 111 ITEM 16. [RESERVED] 112 ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT 112 ITEM 16B. CODE OF ETHICS 112 ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES 112 ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES 113 ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS 113 ITEM 16F. CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT 113 ITEM 16G. CORPORATE GOVERNANCE 113 ITEM 16H. MINE SAFETY DISCLOSURE 113 ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSEPCTIONS 114 ITEM 16J. INSIDER TRADING POLICIES 114 ITEM 16K. CYBERSECURITY 114 PART III 115 ITEM 17.

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS 115 ITEM 18.

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS 115 ITEM 19. EXHIBITS 115 i INTRODUCTION In this annual report on Form 20-F, unless the context otherwise requires, references to: "China" or the "PRC" are to the PRC; "Class A Ordinary Shares" are to Class A ordinary shares of Haoxi Cayman (as defined below), par value $0.0001 per share. Each Class A Ordinary Share is entitled to one vote; "Class B Ordinary Shares" are to Class B ordinary shares of Haoxi Cayman (as defined below), par value $0.0001 per share. Each Class A Ordinary Share is entitled to 10 vote; "Haoxi Beijing" or "the operating entity" are to Beijing Haoxi Digital Technology Co., Ltd., a limited liability company organized under PRC laws and regulations, which company is wholly owned by WFOE (as defined below); "Haoxi HK" are to Haoxi Information Limited, a Hong Kong corporation and wholly owned subsidiary of Haoxi Cayman (as defined below); "Renminbi" or "RMB" are to the legal currency of China; "SEC" are to the U.S. Securities and Exchange Commission; "U.S. dollars," "$," and "dollars" are to the legal currency of the U.S.; "we," "us," "our," "Haoxi Cayman," "our Company," and the "Company" are to Haoxi Health Technology Limited, an exempted company limited by shares incorporated under the laws of the Cayman Islands; and "WFOE" are to Beijing Haoxi Health Technology Co., Limited, a limited liability company organized under the laws and regulations of China, which company is wholly owned by Haoxi HK. Haoxi Cayman is a Cayman Islands holding company. Our business is conducted by our subsidiary, Haoxi Beijing, in China using RMB. Our consolidated financial statements are presented in U.S. dollars. In this annual report, we refer to assets, obligations, commitments, and liabilities in our consolidated financial statements in U.S. dollars. These dollar references are based on the exchange rate of RMB to U.S. dollars, determined as of a specific date or for a specific period. Changes in the exchange ra

IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS Not Applicable.

OFFER STATISTICS AND EXPECTED TIMETABLE

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE Not Applicable.

KEY INFORMATION

ITEM 3. KEY INFORMATION We are a holding company incorporated in the Cayman Islands with no material operations of our own and are not a Chinese operating company. Our operations are conducted in China through our wholly owned indirect PRC subsidiary, Haoxi Beijing, or the operating entity. The operating entity is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. The growth of the operating entity in recent years has benefited from the quick increase of news feed ads, its major form of ad placement, in the industry of online marketing in China. In addition, the healthcare industry in China has developed rapidly because of the growth of average income and the aging population, which provides a conducive environment for the development of the operating entity's business. The operating entity has a management team with several years of experience in marketing for healthcare companies. Its own data analysis software, "Bidding Compass," has helped it obtain ad placement data. Moreover, it has developed a stable placement with mainstream online advertising platforms in China and has been working closely with them since its establishment in 2018. We generate our revenue through the operating entity by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through the operating entity's media partners. The operating entity provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms. The operating entity has served approximately 2,000 advertisers since its incorporation in 2018, the majority of which are healthcare companies. During the fiscal years ended June 30, 2024, 2023, and 2022, it served 543, 393 and 243 advertiser customers, respectively, of which 471, 341 and 12

View Full Filing

View this 20-F filing on SEC EDGAR